Pharminent

GSK seeks EU approval for inhaled triple combo COPD therapy

GlaxoSmithKline (GSK) is seeking approval in Europe for once-daily closed triple combination therapy to treat chronic obstructive pulmonary disease (COPD) patients. http://www.pharmaceutical-business-review.com/news/gsk-and-innoviva-seek-eu-approval-for-copd-therapy-candidate-051216-5687325

Filed under: COPD